Skip to main content

Advertisement

Table 1 Distribution of the clinical features of patients with oral BSCC, W/MSCC and PDSCC

From: Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?

Clinical features No. of cases (%)
  BSCC PDSCC W/MSCC p value*
Sex        
 Male 15 88.2 25 96.1 26 92.9 NA
 Female 2 11.8 1 3.9 2 7.1
Ethnic group        
 White 15 88.2 22 84.6 24 85.7 NA
 Non-White 2 11.8 4 15.4 4 14.3
Age, y        
 ≤ 59 7 41.2 15 57.7 16 57.1 .504
 > 59 10 58.8 11 42.3 12 42.9
Tobacco#        
 Yes 12 85.7 22 91.7 22 88.0 NA
 No 2 14.3 2 8.3 3 12.0
Alcohol#        
 Yes 10 76.9 21 87.5 22 88.0 NA
 No 3 23.1 3 12.5 3 12.0
Clinical T classification        
 T1 - 2 5 29.4 6 23.1 9 32.1 .754
 T3 - 4 12 70.6 20 76.9 19 67.9
Clinical N classification        
 N0 5 29.4 8 30.8 9 32.1 .981
 N1 - 2 - 3 12 70.6 18 69.2 19 67.9
Tumor site        
 Tongue 3 17.7 5 19.3 7 25.0 NA
 Floor of mouth 10 58.8 9 34.6 8 28.6
 Retromolar/gingiva 4 23.5 12 46.1 13 46.4
Neck dissection        
 Without 0 0.0 0 0.0 1 3.6 NA
 Ipsilateral 9 53.0 19 73.0 22 78.6
 Bilateral 8 47.0 7 27.0 5 17.8
Radiotherapy        
 Yes 15 88.2 22 84.6 18 64.3 NA
 No 2 11.8 4 15.4 10 35.7
Chemotherapy        
 Yes 3 17.7 7 26.9 5 17.9 NA
 No 14 82.3 19 73.1 23 82.1
Total 17 100 26 100 28 100  
  1. Abbreviations: BSCC basaloid squamous cell carcinoma, PDSCC poorly differentiated squamous cell carcinoma, W/MSCC well to moderately differentiated squamous cell carcinoma, NAnot applicable.
  2. *Analysis by chi-square test at 5% significance level.
  3. #Excluding patients with lost records.